AGP Executive Report
Last update: 10 hours agoClinical Trials: Zuellig Pharma has acquired a licensed facility in Hangzhou, expanding local drug sourcing and cold-chain support for clinical trials in China. Mental Health: Japan’s depression-care gap goes beyond stigma: a shortage of psychiatrists leaves many first diagnoses and prescriptions to general practitioners, while follow-up can be hard to access. Weight Management: A University of Auckland survey found 70% of Pacific participants viewed weight-loss medication as acceptable, but more than 90% worried about cost. Healthcare Costs: India’s medical costs are forecast to rise 10.1% in 2027, faster than general inflation, despite easing from this year’s projected increase. Medicine Access: India plans to expand authorised import gateways for drugs and medical devices, aiming to streamline access. Disease Preparedness: Singapore has launched an Asia-Pacific initiative to spot emerging infectious disease threats earlier. Air Quality: Worsening smog across India and Pakistan is renewing concern over the health toll of severe air pollution.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
